Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
What the trial team says
This study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer agents in participants with advanced cancer that has recurred/progressed.
Key facts
- Registry number
- NCT05417594
- Stage of testing
- Phase 1/Phase 2
- Conditions studied
- Advanced Solid Malignancies
Where it is running
This trial lists 32 sites.
-
Australia
- Research Site (Darlinghurst)
- Research Site (Melbourne)
- Research Site (Randwick)
-
California
- Research Site (La Jolla)
- Research Site (Los Angeles)
- Research Site (San Francisco)
-
Germany
- Research Site (Bayern)
- Research Site (Berlin)
- Research Site (Heidelberg)
- Research Site (Mainz)
-
Illinois
- Research Site (Chicago)
-
Massachusetts
- Research Site (Boston)
-
New York
- Research Site (New York)
- Research Site (New York)
-
Oregon
- Research Site (Portland)
-
South Korea
- Research Site (Seoul)
- Research Site (Seoul)
- Research Site (Seoul)
-
Spain
- Research Site (A Coruña)
- Research Site (Barcelona)
- Research Site (Málaga)
- Research Site (Pozuelo de Alarcón)
- Research Site (Sant Cugat del Vallès)
- Research Site (Seville)
-
Sweden
- Research Site (Lund)
- Research Site (Stockholm)
-
Texas
- Research Site (Houston)
- Research Site (San Antonio)
-
United Kingdom
- Research Site (Glasgow, Scotland)
- Research Site (London)
- Research Site (Newcastle upon Tyne)
-
Virginia
- Research Site (Richmond)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.